News Archives - Page 349 of 703

TuesdaySep 14, 2021 2:06 pm

DGE’s 2nd REMS Virtual Summit to Draw Pharmaceutical and Life Science Professionals

Date: October 11-12, 2021 Online Livestream Dynamic Global Events (“DGE”) is proud to announce its 2nd Risk Evaluation and Mitigation Strategies (“REMS”) virtual summit. This two-day event, scheduled for October 11-12, 2021, will be an excellent avenue for life science professionals to develop decision making skills to adapt to anticipate FDA feedback with ease. This virtual conference is an exceptional resource for gaining new insights into adapting to risk mitigation strategies regarding submissions and modifications. DGE has partnered with BioMed Wire, Pharma Voice, Pharma Marketing Networks, and FDA News Watch, among other enterprises, to offer a wholesome experience to event…

TuesdaySep 14, 2021 10:51 am

Ammonia’s Potential as Clean Hydrogen Carrier Illustrates a Key Benefit of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Technology

Canadian-based growth-stage company FuelPositive Corp. is building prototypes for a commercially viable and sustainable clean energy ammonia production system that can enable the hydrogen economy by making the transportation and storage of hydrogen easy and economical Ammonia has been a carbon-intense industry, but FuelPositive’s Phase 2 Hydrogen-Ammonia Synthesizer is a highly portable and scalable patent-pending solution for rolling out a carbon-free, on site production model to end users A report by scientific and technological innovation magazine New Atlas weighs the potential benefits of using ammonia as a means of storing hydrogen for green energy, including ammonia’s ability to “do a…

TuesdaySep 14, 2021 9:42 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Likely to Benefit from New Research Touting Psilocybin Mental Health Treatments

Yale researchers publish study that a single dose of psilocybin counteracts symptoms of depression Administering drug to mice resulted in an approximately 10% increase in neuron size and density Cybin is focused on progressing psychedelic therapeutics As news of psychedelic research continues to report breakthroughs — such as the recent news from a group of Yale researchers that a single dose of psilocybin counteracts symptoms of depression (https://ibn.fm/NCORl) — companies operating in the space, including Cybin (NEO: CYBN) (NYSE American: CYBN), are ideally positioned to see significant benefits and growth. “Yale researchers found that a single dose of the naturally occurring psychedelic compound psilocybin…

TuesdaySep 14, 2021 9:03 am

SRAX Inc. (NASDAQ: SRAX) Gears up for Its First Ever 2021 Sequire EdTech Conference, Announces EdTech Heavyweights as Keynote Speakers

2021 Sequire EdTech Conference announces keynote speaker lineup and agenda featuring founders and leaders of EdTech big names such as Udemy, HolonIQ, Amesite, and more Online education and remote work sector have exploded over the past years, attracting growing attention from investors Conference aims to bring this growing sector closer to diverse investor audiences, including institutional and retail investors, family offices, venture capitalists and private equity firms, and public and emerging growth companies SRAX (NASDAQ: SRAX), a financial technology company that developed Sequire, a SaaS platform designed to unlock data and insights for publicly traded companies, has announced an impressive…

MondaySep 13, 2021 2:58 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Impressive Blood Pressure Reduction in Hypertension Clinical Trials

Lexaria Bioscience has developed a patented technology that improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing Lexaria’s patented DehydraTECH (TM) technology is undergoing human clinical trials this year to determine its effectiveness in making cannabidiol (“CBD”) effective as a means of reducing blood pressure for high blood pressure patients The initial results of the first human clinical study showed the DehydraTECH-CBD compound was well tolerated by patients without troubling side effects and that the compound outperformed generic CBD controls Just-released initial (partial) results regarding the compound’s second human clinical trial show that a three-dose regimen…

MondaySep 13, 2021 2:05 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 Outlook

So far in 2021, Tryp’s innovations have allowed it to position itself as a first-mover in the psychedelics space The company has announced completion of psychotherapy training for the upcoming phase 2a clinical trials for specific overeating disorders Tryp has also been keen on collaborating and partnering with key players in the industry, such as Calvert Labs and Gad Consulting services, the University of Michigan, and the University of Florida The company also understands the value of proper leadership and, so far in 2021, it has made strategic appointments to its board of directors Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF)…

MondaySep 13, 2021 1:43 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Empowering Pharmacists to Better Help Family Physicians and Patients

Through HealthTab, its flagship offering, Avricore turns pharmacies into community diagnostic centers by providing a turnkey point-of-care testing platform HealthTab is a multilayered operational ecosystem that provides endless possibilities, from lab-accurate tests to immediate results uploaded automatically on a web-based platform It enables patients to review the results on the spot with the pharmacist, allowing pharmacists to take on a more significant role in primary health services HealthTab ultimately aims to improve the quality of life for patients living with chronic illnesses A recent McKinsey article observed that consumers deeply care about wellness now more than ever; this interest is…

MondaySep 13, 2021 1:35 pm

reAlpha Set to Advance Innovative Short-Term Rental Platform Following $6 Million Investment Round

The $6 million investment round was led by Crawford Hoying, a real estate holding company with more than $1.3 billion of mixed-use, multifamily, office, and retail properties The company is taking advantage of the new wave of investment opportunities in the emerging industry Airbnb has created Equity in reAlpha properties can be purchased for as little as $2,500 and handled much like buying stock in a company. Investors are matched with like-minded backers to cover the down payment on properties reAlpha, often referred to as the Robinhood of Airbnb investments, recently announced that it has closed on a $6 million…

MondaySep 13, 2021 1:15 pm

DGE’s 7th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare – Virtual Conference On Women Leadership Roles

Date: September 22-24, 2021 Online Livestream Pharma professionals, healthcare providers, influencers, and healthcare-related industries are invited to attend DGE’s 7th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare being held on September 22-24, 2021, as a live online event. The event is organized by Dynamic Global Events (“DGE”), a Life Science leader in hosting B2B events. This global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. Women executives in the pharma and healthcare sector face numerous hurdles to reach the echelon of success. The event will feature such…

MondaySep 13, 2021 1:00 pm

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Files for National Medical Products Administration Registration of Early-Warning Cancer Technology with a Record 11 Tumor Types Under Formal Medical Device Product Registration

AnPac Bio-Medical Science Co., Ltd. has developed its proprietary Cancer Differentiation Analysis (“CDA”) technology to detect biophysical signals as an alternative early disease indicator to blood-based biomarker testing for cancer The company has laboratories and R&D facilities in China equipped for CDA testing and cancer biochemical testing, as well as a CLIA/CAP accredited laboratory in the United States AnPac Bio recently held its 2021 technical symposium in China where KOLs from major hospitals and universities discussed new technologies for cancer detection and treatment. AnPac Bio-Medical Science (NASDAQ: ANPC) is moving forward with testing and registration of its multi-cancer screening technology…

Site Search

Company Search

Category: News